Feasibility of Frequent Patient-Reported Outcome Surveillance in Patients Undergoing Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 3, 2013, Pages 450-459

  Wood, William A ^a   Deal, Allison M ^b   Abernethy, Amy ^c   Basch, Ethan ^a   Battaglini, Claudio ^d   Kim, Yoon Hie ^e   Whitley, Julia ^a   Shatten, Charlotte ^a   Serody, Jon ^a   Shea, Thomas ^a   Reeve, Bryce B ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Allogeneic transplantation; Autologous transplantation; Health related quality of life; Symptoms

Indexed keywords

BUSULFAN; FLUDARABINE; MELPHALAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; APLASTIC ANEMIA; ARTHRALGIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COHORT ANALYSIS; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRY SKIN; FATIGUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HAIR LOSS; HOSPITAL DISCHARGE; HUMAN; INSOMNIA; LIMB SWELLING; LONG TERM CARE; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PARESTHESIA; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; REDUCED INTENSITY CONDITIONING; SCORING SYSTEM; SELF REPORT; URINARY FREQUENCY; XEROSTOMIA;

AGED; ELECTRONIC HEALTH RECORDS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYELOABLATIVE AGONISTS; QUALITY OF LIFE; SELF REPORT; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84873586777     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.11.014     Document Type: Article

References (30)

1. Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2011. Available from:. Accessed October 18, 2012. http://www.cibmtr.org.
2. Lee S.J., Fairclough D., Parsons S.K., et al. Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol 2001, 19:242-252.
3. Wingard J.R., Huang I.C., Sobocinski K.A., et al. Factors associated with self-reported physical and mental health after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010, 12:1682-1692.
4. Andrykowski M.A., Bishop M.M., Hahn E.A., et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 2005, 23:599-608.
5. Pidala J., Anasetti C., Jim H. Quality of life after allogeneic hematopoietic cell transplantation. Blood 2009, 114:7-19.
6. Bevans M. Health-related quality of life following allogeneic hematopoietic stem cell transplantation. Hematology Am Soc Hematol Educ Program 2010, 2010:248-254.
7. Cohen M.Z., Rozmus C.L., Mendoza T.R., et al. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage 2012, 44:168-180.
8. Bevans M.F., Mitchell S.A., Marden S. The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Support Care Cancer 2008, 16:1243-1254.
9. Bevans M.F., Marden S., Leidy N.K., et al. Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006, 38:101-109.
10. Pidala J., Kurland B.F., Chai X., et al. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium. Haematologica 2011, 96:1528-1535.
11. Lee S.J., Williams L.A. Patient-reported outcomes for acute graft-versus-host disease prevention and treatment trials. Biol Blood Marrow Transplant 2010, 16:295-300.
12. Gupta V., Panzarella T., Li L., et al. A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioning. Biol Blood Marrow Transplant 2012, 18:113-124.
13. Andersson I., Ahlberg K., Stockelberg D., et al. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning. Cancer Nurs 2009, 32:325-334.
14. Basch E.M., Reeve B.B., Mitchell S.A., et al. Electronic toxicity monitoring and patient-reported outcomes. Cancer J 2011, 17:231-234.
15. National Cancer Institute. Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Available from:. Accessed October 18, 2012. http://outcomes.cancer.gov/tools/pro-ctcae.html.
16. Hays R.D., Bjorner J.B., Revicki D.A., et al. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res 2009, 18:873-880.
17. Abernethy A.P., Herndon J.E., Wheeler J.L., et al. Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. Health Serv Res 2008, 43:1975-1991.
18. Abernethy A., Herndon J.E., Wheeler J.L., et al. Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology. J Pain Symptom Manage 2009, 37:1027-1038.
19. Gratwohl A. The EBMT risk score. Bone Marrow Transplant 2012, 47:749-756.
20. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.
21. Andikyan V., Rezk Y., Einstein M.H., et al. A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery. Gynecol Oncol 2012, 127:273-277.
22. Cook K.F., O'Malley K.G., Roddey T.S. Dynamic assessment of health outcomes: time to let the CAT out of the bag?. Health Serv Res 2005, 40(Part II):1694-1711.
23. Basch E., Artz D., Dulko D., et al. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol 2005, 23:3552-3561.
24. Berry D.L., Blumenstein B.A., Halpenny B., et al. Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol 2011, 29:1029-1035.
25. Cleeland C.S., Wang X.S., Shi Q., et al. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol 2011, 29:994-1000.
26. Cella D., Riley W., Stone A., et al. Initial item banks and first wave testing of the Patient-Reported Outcomes Measurement Information Systems (PROMIS) Network, 2005-2008. J Clin Epidemiol 2010, 63:1179-1194.
27. Wang X.S., Shi Q., Williams L.A., et al. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer 2008, 113:2102-2109.
28. Shi Q., Smith T.G., Michonski J.D., et al. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's studies of cancer survivors. Cancer 2011, 117:2779-2790.
29. Anderson K.O., Giralt S.A., Mendoza T.R., et al. Symptom burden in patients undergoing autologous stem cell transplantation. Bone Marrow Transplant 2007, 39:759-766.
30. Basch E., Abernethy A.P., Mullins D., et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 2012, 30:4249-4255.